BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 7593602)

  • 1. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice.
    Bellosta S; Mahley RW; Sanan DA; Murata J; Newland DL; Taylor JM; Pitas RE
    J Clin Invest; 1995 Nov; 96(5):2170-9. PubMed ID: 7593602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma.
    Zhu Y; Bellosta S; Langer C; Bernini F; Pitas RE; Mahley RW; Assmann G; von Eckardstein A
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7585-90. PubMed ID: 9636193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages.
    Fazio S; Babaev VR; Murray AB; Hasty AH; Carter KJ; Gleaves LA; Atkinson JB; Linton MF
    Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4647-52. PubMed ID: 9114045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels.
    Raffai RL; Loeb SM; Weisgraber KH
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):436-41. PubMed ID: 15591220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein CI aggravates atherosclerosis development in ApoE-knockout mice despite mediating cholesterol efflux from macrophages.
    Westerterp M; Van Eck M; de Haan W; Offerman EH; Van Berkel TJ; Havekes LM; Rensen PC
    Atherosclerosis; 2007 Nov; 195(1):e9-16. PubMed ID: 17320883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
    Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient mice.
    Tsukamoto K; Tangirala RK; Chun S; Usher D; Puré E; Rader DJ
    Mol Ther; 2000 Feb; 1(2):189-94. PubMed ID: 10933930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage-specific apoE gene repair reduces diet-induced hyperlipidemia and atherosclerosis in hypomorphic Apoe mice.
    Gaudreault N; Kumar N; Olivas VR; Eberlé D; Rapp JH; Raffai RL
    PLoS One; 2012; 7(5):e35816. PubMed ID: 22606237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid regression of atherosclerosis induced by liver-directed gene transfer of ApoE in ApoE-deficient mice.
    Tsukamoto K; Tangirala R; Chun SH; Puré E; Rader DJ
    Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2162-70. PubMed ID: 10479659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial overexpression of Fas ligand decreases atherosclerosis in apolipoprotein E-deficient mice.
    Yang J; Sato K; Aprahamian T; Brown NJ; Hutcheson J; Bialik A; Perlman H; Walsh K
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1466-73. PubMed ID: 15178561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall.
    Shimano H; Ohsuga J; Shimada M; Namba Y; Gotoda T; Harada K; Katsuki M; Yazaki Y; Yamada N
    J Clin Invest; 1995 Feb; 95(2):469-76. PubMed ID: 7860728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ApoA1 reduces free cholesterol accumulation in atherosclerotic lesions of ApoE-deficient mice transplanted with ApoE-expressing macrophages.
    Boisvert WA; Black AS; Curtiss LK
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):525-30. PubMed ID: 10073953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of macrophage-expressed adipocyte fatty acid binding protein in the development of accelerated atherosclerosis in hypercholesterolemic mice.
    Layne MD; Patel A; Chen YH; Rebel VI; Carvajal IM; Pellacani A; Ith B; Zhao D; Schreiber BM; Yet SF; Lee ME; Storch J; Perrella MA
    FASEB J; 2001 Dec; 15(14):2733-5. PubMed ID: 11606480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis.
    Sullivan PM; Mezdour H; Aratani Y; Knouff C; Najib J; Reddick RL; Quarfordt SH; Maeda N
    J Biol Chem; 1997 Jul; 272(29):17972-80. PubMed ID: 9218423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of atherosclerotic lesions in apo E3-leiden transgenic mice.
    Leppänen P; Luoma JS; Hofker MH; Havekes LM; Ylä-Herttuala S
    Atherosclerosis; 1998 Jan; 136(1):147-52. PubMed ID: 9544741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transplantation in apolipoprotein E-deficient mice. Effect of ApoE gene dosage on serum lipid concentrations, (beta)VLDL catabolism, and atherosclerosis.
    Van Eck M; Herijgers N; Yates J; Pearce NJ; Hoogerbrugge PM; Groot PH; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3117-26. PubMed ID: 9409301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E.
    Tangirala RK; Praticó D; FitzGerald GA; Chun S; Tsukamoto K; Maugeais C; Usher DC; Puré E; Rader DJ
    J Biol Chem; 2001 Jan; 276(1):261-6. PubMed ID: 11024044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of macrophage ApoE on atherosclerosis in LDL-receptor deficient mice.
    Tennert C; Teupser D; Mueller MA; Wilfert W; Renner-Müller I; Stein O; Stein Y; Sippel AE; Wolf E; Thiery J
    Biochem Biophys Res Commun; 2007 Sep; 361(3):574-9. PubMed ID: 17669363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage cholesterol metabolism, apolipoprotein E, and scavenger receptor AI/II mRNA in atherosclerosis-susceptible and -resistant mice.
    Friedman G; Ben-Yehuda A; Dabach Y; Hollander G; Babaey S; Ben-Naim M; Stein O; Stein Y
    Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2459-64. PubMed ID: 11073853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage phospholipid transfer protein deficiency and ApoE secretion: impact on mouse plasma cholesterol levels and atherosclerosis.
    Liu R; Hojjati MR; Devlin CM; Hansen IH; Jiang XC
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):190-6. PubMed ID: 17038631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.